Adding non responses rate of 10%, a total sample size of 417 delivering mothers were included.
Completed questionnaires were received from nine doctoral students, six supervisors, and three country PIs (86% responses rate).
The low responses rate of 34% was primarily a function of the large number of clients that were nominated by case managers that did not meet selection criteria.
The responses rate was excellent; 135/137 (98.5%) patients completed the acceptance section of the ARQ, and 2/137 (1.5%) patients had >2 missing answers.
Among the CM cases, associations between 25(OH D levels and disease severity at presentation, baseline CSF immune responses, rate of clearance of infection, and mortality were examined using linear and Cox regression modeling.
Relationship to clinical response to chemotherapy (Table 2) demonstrated that objective response (complete and partial responses) rate of the group with GSTM1-null genotype (75.5%) did not differ from that in those with GSTM1-positive genotype (76.9%).
